Familial Hypercholesterolemia and Lipoprotein Apheresis.

Makino, Hisashi; Koezuka, Ryo; Tamanaha, Tamiko; Ogura, Masatsune; Matsuki, Kota; Hosoda, Kiminori; Harada-Shiba, Mariko

Makino, Hisashi; Koezuka, Ryo; Tamanaha, Tamiko; Ogura, Masatsune; Matsuki, Kota; Hosoda, Kiminori; Harada-Shiba, Mariko.

Afiliación

Makino H; Department of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center.
Koezuka R; Department of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center.
Tamanaha T; Department of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center.
Ogura M; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
Matsuki K; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.
Hosoda K; Department of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center.
Harada-Shiba M; Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute.

J Atheroscler Thromb ; 26(8): 679-687, 2019 Aug 01.

Article en En | MEDLINE | ID: mdl-31231083

Asunto(s)

Aterosclerosis/prevención & control; Hiperlipoproteinemia Tipo II/terapia; Lipoproteínas/sangre; Humanos; Hiperlipoproteinemia Tipo II/sangre

Palabras clave

Atherosclerotic cardiovascular disease; Familial hypercholesterolemia; Lipoprotein apheresis; MTP inhibitor; PCSK9 inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Aterosclerosis / Hiperlipoproteinemia Tipo II / Lipoproteínas Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Atheroscler Thromb Asunto de la revista: ANGIOLOGIA Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google